AHA Journals, Author Interviews, Biomarkers, Heart Disease / 08.08.2014
Which BNP Better Predicts CV Events in Stable Coronary Heart Disease?
MedicalResearch.com Interview with:
Rakesh K. Mishra, MD
San Francisco Veterans Affairs Medical Center
San Francisco, CA 94121.
Medical Research: What are the main findings of the study?
Dr. Mishra: Increased levels of both BNP and NT-proBNP are associated with elevated risk of adverse cardiovascular events in patients with stable coronary artery disease. However, when added to existing clinical models of risk, NT-proBNP is superior to BNP for risk reclassification.
(more…)